A M Taylor Selected Research

Homogentisic Acid

1/2019	Raman Spectroscopy identifies differences in ochronotic and non-ochronotic cartilage; a potential novel technique for monitoring ochronosis.
7/2016	A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria.
2/2016	Osteoarticular cells tolerate short-term exposure to nitisinone-implications in alkaptonuria.
12/2011	The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria.
2/2010	Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A M Taylor Research Topics

Disease

5	Alkaptonuria 01/2019 - 02/2010
3	Neoplasms (Cancer) 01/2021 - 03/2001
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2012 - 08/2001
2	Ochronosis 07/2016 - 02/2016
2	Breast Neoplasms (Breast Cancer) 01/2012 - 08/2011
1	Paralysis (Palsy) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Inflammation (Inflammations) 01/2017
1	Osteoarthritis 07/2016
1	Wounds and Injuries (Trauma) 07/2016
1	Aortic Valve Stenosis (Aortic Stenosis) 02/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2011
1	Calculi (Calculus) 02/2010
1	Cicatrix (Scar) 09/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2009
1	Coronary Disease (Coronary Heart Disease) 08/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2009
1	Acidosis 09/2006
1	Malaria 09/2006
1	Hypoxia (Hypoxemia) 09/2006
1	Cerebral Malaria 09/2006
1	Pulmonary Artery Stenosis 07/2006
1	Congenital Heart Defects (Congenital Heart Defect) 07/2006
1	Leukemia 12/2001
1	Nervous System Diseases (Neurological Disorders) 08/2001
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2001

Drug/Important Bio-Agent (IBA)

5	Homogentisic AcidIBA 01/2019 - 02/2010
3	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 12/2011
3	Phosphotransferases (Kinase)IBA 08/2011 - 08/2001
2	Proteins (Proteins, Gene)FDA Link 08/2001 - 08/2001
1	Immune Checkpoint InhibitorsIBA 01/2021
1	HDL LipoproteinsIBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	LipidsIBA 01/2017
1	CytokinesIBA 07/2016
1	InterleukinsIBA 07/2016
1	Interleukin-6 (Interleukin 6)IBA 07/2016
1	nitisinone (Orfadin)FDA Link 02/2016
1	SaltsIBA 02/2010
1	EnzymesIBA 02/2010
1	PolymersIBA 02/2010
1	CalciumIBA 02/2010
1	Homogentisate 1,2-Dioxygenase (Homogentisate 1,2 Dioxygenase)IBA 02/2010
1	GadoliniumIBA 09/2009
1	MyoglobinIBA 09/2006
1	Muscle Proteins (Muscle Protein)IBA 09/2006
1	Radioisotopes (Radionuclides)IBA 07/2006
1	IsotopesIBA 07/2006
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2001
1	DNA (Deoxyribonucleic Acid)IBA 08/2001

Therapy/Procedure

3	Therapeutics 01/2021 - 08/2009
1	Immunotherapy 01/2021
1	Bariatric Surgery 01/2017
1	Transcatheter Aortic Valve Replacement 02/2012
1	Radiotherapy 01/2012
1	Transplantation 08/2009
1	Kidney Transplantation 08/2009
1	Drug Therapy (Chemotherapy) 03/2001
1	Radioimmunotherapy 03/2001